Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease

被引:27
|
作者
Li, Xiaoyan [1 ]
Wang, Hua [1 ,2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei 230022, Peoples R China
[2] Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Peoples R China
来源
CELL AND BIOSCIENCE | 2020年 / 10卷 / 01期
关键词
Non-alcoholic fatty liver disease; Energy metabolism; Lipid; Hormone; Inter-organ crosstalk; BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; GROWTH-FACTOR; 21; ENDOPLASMIC-RETICULUM STRESS; HEPATIC LIPID-METABOLISM; RECEPTOR-DEFICIENT MICE; INSULIN-RESISTANCE; GUT MICROBIOTA; ENERGY-METABOLISM; EXTRAHEPATIC COMPLICATIONS;
D O I
10.1186/s13578-020-00507-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) represents the leading cause of chronic liver disease worldwide and the anticipated health burden is huge. There are limited therapeutic approaches for NAFLD now. It's imperative to get a better understanding of the disease pathogenesis if new treatments are to be discovered. As the hepatic manifestation of metabolic syndrome, this disease involves complex interactions between different organs and regulatory pathways. It's increasingly clear that brain, gut and adipose tissue all contribute to NAFLD pathogenesis and development, in view of their roles in energy homeostasis. In the present review, we try to summarize currently available data regarding NAFLD pathogenesis and to lay a particular emphasis on the inter-organ crosstalk evidence.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15
  • [42] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [43] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377
  • [44] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [45] Non-alcoholic fatty liver disease
    Bjornsson, Einar
    Angulo, Paul
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
  • [46] Non-alcoholic fatty liver disease
    Cua, IHY
    George, J
    HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111
  • [47] Molecular pathways involved in the improvement of non-alcoholic fatty liver disease
    Paz-Filho, Gilberto
    Mastronardi, Claudio Alberto
    Parker, Brian J.
    Khan, Ainy
    Inserra, Antonio
    Matthaei, Klaus I.
    Ehrhart-Bornstein, Monika
    Bornstein, Stefan
    Wong, Ma-Li
    Licinio, Julio
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2013, 51 (01) : 167 - 179
  • [48] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [49] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [50] Non-alcoholic fatty liver disease
    Farrell, Geoffrey C.
    Wardell, Rebecca
    Teoh, Narci
    Chitturi, Shiv
    INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683